Eli Lilly | LLY - Stock

Aktienkurs
988.09
Täglich Wechseln
-16.83 -1.67%
Monatlich
7.41%
Jährlich
30.85%
Q2 Prognose
984.72




Stock Veränderung Datum
AbbVie USD 5.05B 98M 2026-03
Abbott USD 6.99B 501M 2026-03
ALKERMES USD 336.7M 140.08M 2026-03
Amgen USD 6.19B 39M 2026-03
AstraZeneca USD 6.57B 13M 2026-03
Baxter International USD 2.32B 84M 2026-03
Biogen USD 1.95B 219.1M 2026-03
Bristol-Myers Squibb USD 2.76B 66M 2026-03
Coherus Biosciences USD 3.17M 1.12M 2025-12
Drreddys Laboratories INR 79.01B 3.41B 2025-12
Eli Lilly USD 14.53B 785M 2026-03
Gilead Sciences USD 1.91B 140M 2026-03
GlaxoSmithKline GBP 6.16B 233M 2026-03
Glaxosmithkline GBP 6.12B 46M 2025-09
J&J USD 14.58B 392M 2026-03
Medtronic USD 6.31B 153M 2025-12
Merck USD 6.48B 179M 2026-03
Neurocrine Biosciences USD 64.5M 4.5M 2026-03
Novartis USD 6.29B 17M 2026-03
Novartis USD 6.42B 114M 2025-09
Novo Nordisk DKK 45.65B 21.26B 2025-06
Perrigo USD 1.12B 27.6M 2026-03
Pfizer USD 10.67B 13M 2026-03
Phibro Animal Health USD 539.7M 22.35M 2026-03
Prestige Brands USD 159.13M 4.46M 2026-03
Regeneron Pharmaceuticals USD 3.1B 97.2M 2026-03
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 22.69B 1.81B 2025-12
Sanofi EUR 22.69B 1.81B 2025-12
United Therapeutics USD 178.3M 4.8M 2026-03
Zoetis USD 2.55B 120M 2026-03